Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(30 sites)
China
Chongqing University Three Gorges Hospital, Chongqing, Chongqing Municipality Daping Hospital, The Third Military Medical University, Chongqing, Chongqing Municipality Gansu Provincal Central Hospital, Lanzhou, Gansu Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Tongji Hospital, Wuhan, Hubei The First Hospital of Changsha City, Changsha, Hunan The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi General Hospital of Ningxia Medical University, Yinchuan, Ningxia Shaanxi Second Provincal People's Hospital, Xi'an, Shaanxi Tangdu Hospital, Xi'an, Shaanxi The first affiliated hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Xi'an Central Hospital, Xi'an, Shaanxi Department of Neurology, Xijing Hospital, Xi'an, Shaanxi Shannxi Provincal People's Hospital, Xi'an, Shaanxi The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi Xi'an Gaoxin Hospital, Xi'an, Shaanxi Xi'an No.3 Hospital, Xi'an, Shaanxi Xianyang Hospital, Yan'an University, Xianyang, Shaanxi The First People's Hospital of Xianyang, Xianyang, Shaanxi Yulin No.1 Hospital, Yulin, Shaanxi Yulin No.2 Hospital, Yulin, Shaanxi Qilu Hospital of Shangdong University, Jinan, Shandong The PLA 960 Hospital, Jinan, Shandong The Second Hospital of Shandong University, Jinan, Shandong Liaocheng People's Hospital, Liaocheng, Shandong People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, Xinjiang The Second Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang